Página 4 - Melhores Oncologia Hematológica hematologistas-oncologistas - TOP-171 médicos

Especialista em transplantes de células-tronco autólogos e alogénicos para leucemias e linfomas nos Hospitais Valued Med Hub.

• Professor Associado com vasta experiência em hematologia
• Especialista no tratamento de leucemias agudas e crónicas, incluindo LMA e LLA
• Foca-se em linfomas de Hodgkin e não-Hodgkin
• Formado no Hospital de Pesquisa e Treinamento em Oncologia de Ankara – um importante centro de hematologia

A Dra. Carmen Martínez Chamorro é especialista em transplantes de medula óssea em adultos para leucemia, linfoma e mieloma no Quironsalud Madrid.

• Subchefe de Hematologia no Quironsalud Madrid
• Autora de 20 artigos médicos e participante em 60 conferências
• Formada no Hospital Universitário La Princesa em Madrid
• Vencedora do Prémio Nacional de Investigação em Cirurgia

O Professor Drach realizou mais de 1.100 procedimentos oncológicos e liderou o programa de Mieloma Múltiplo e Linfoma Maligno no Hospital Universitário de Viena – um dos maiores da Europa.

• Especialista em oncologia hematológica com mais de 25 anos de experiência
• Ex-médico-chefe do Hospital Universitário de Medicina Interna I de Viena
• Publicou mais de 120 artigos científicos sobre hematologia e oncologia
• Membro da diretoria da Sociedade Austríaca de Hematologia e Oncologia
• Oferece segundas opiniões e otimização de terapia pré-cirúrgica

O Professor Hasan Atilla Ozkan lidera a Associação Turca de Aférese Terapêutica e é especialista em transplante de células-tronco no Hospital VM Medical Park Pendik.

• Mais de 20 anos de experiência em hematologia e transplante de medula óssea
• Certificado em transplante de células-tronco autólogas e alogénicas pela EBMT
• Professor atual na Faculdade de Medicina da Universidade Yeditepe
• Vencedor do Prémio de Jovem Investigador em Aférese Terapêutica

Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.

Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.

Dr. Osman Ilhan is a Professor of Internal Diseases. He earned his medical degree at Ankara University in 1978. He completed his specialization in Internal Diseases there in 1982. He became an Associate Professor in 1990 and a Professor in 1996.

He served as a professor at Ankara University from 1997 to 2022. He has worked at Lokman Hekim Akay Hospital since 2023. Earlier, he held roles at MD Anderson Cancer Center (1996–1997), Ankara University (1978–1983; 1988–1995), GATA (1984–1985), and Ulus Hospital (1985–1988).

Mais de 1.100 procedimentos de linfoma realizados – O Prof. Weidmann chefia a Hematologia na Clínica Nordwest, um centro líder em distúrbios sanguíneos.

• Especialista em cuidados de linfoma de Hodgkin e não-Hodgkin
• Professor com vasta experiência acadêmica e clínica
• Mais de 30 anos focado em tratamentos de distúrbios sanguíneos
• Lidera um dos principais departamentos de hematologia da Alemanha

Listado pela Forbes como um dos melhores médicos de Israel – o Dr. Goldstein lidera a Oncologia Pediátrica no Hadassah Medical Center.

• Especializado em hemato-oncologia pediátrica há mais de 20 anos
• Especialista em retinoblastoma e abordagens de medicina de precisão
• Realiza transplantes de medula óssea haploidênticos para crianças
• Membro de quatro associações internacionais de oncologia pediátrica

O Prof. Reuven Or lidera o Departamento de Hematologia e Transplante de Medula Óssea do Hadassah – pioneiro em imunoterapia do cancro e terapia celular.

• Mais de 15 anos de especialização em transplantes de medula óssea e cancros hematológicos
• Diretor Médico do Banco Nacional de Sangue de Israel e do Registo Público de Medula Óssea
• Destinatário do prestigiado Prémio Menachem Begin por conquistas médicas
• Formado em instituições de topo em Itália e nos EUA
• Publicou vários artigos de investigação em revistas médicas

Especialista em cancros hematológicos e transplantes avançados de medula óssea – o Dr. Alemdar combina a excelência académica na Universidade de Akdeniz com mais de 15 anos de prática clínica.

• Especialista certificado em Oncologia Médica com formação adicional em Medicina Interna
• Especialista em terapia de células CAR-T e transplantes haploidênticos de células estaminais
• Membro da Associação Turca de Oncologia Médica
• Trabalha no Complexo Hospitalar Medical Park Antalya, acreditado pela JCI

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

 Mali interdisciplinary hospital is integrating conventional, regenerative and precision medicine. It divides into 11 departments, there are 35 beds in total, including 12 intensive care beds, 23 general beds, 2 emergency and operating rooms, 1 plastic surgical room, 1 Gastro-colonoscopic room. Focus on round-trip treatment with modern medical technology to reduce the cost of hospitalization and the healing time. It also integrating regenerative medicine to repair the body and precision medicine for preventing and treating chronic non-communicable diseases (NCDs) with better results, we provide these services in a greenery atmosphere. Allowing clients to receive the following benefits.

1. Far away from NCDs & It’s complication

2. Good quality of life

3. Youthful lively life

4. Longevity

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.